4732 Stock Overview
NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
NatureWise Biotech & Medicals Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$24.60 |
| 52 Week High | NT$36.75 |
| 52 Week Low | NT$22.05 |
| Beta | 0.71 |
| 1 Month Change | -2.38% |
| 3 Month Change | -2.38% |
| 1 Year Change | -26.35% |
| 3 Year Change | 6.00% |
| 5 Year Change | 34.76% |
| Change since IPO | 42.73% |
Recent News & Updates
Recent updates
Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E
Apr 29
A Look At The Intrinsic Value Of NatureWise Biotech & Medicals Corporation (GTSM:4732)
Mar 25Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 20
Shareholder Returns
| 4732 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | -2.6% | -4.4% | -2.6% |
| 1Y | -26.3% | -18.4% | 25.9% |
Return vs Industry: 4732 underperformed the TW Personal Products industry which returned -18.4% over the past year.
Return vs Market: 4732 underperformed the TW Market which returned 25.9% over the past year.
Price Volatility
| 4732 volatility | |
|---|---|
| 4732 Average Weekly Movement | 4.2% |
| Personal Products Industry Average Movement | 4.0% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.4% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4732 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4732's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Zhong Yang Huang | www.naturewise.com.tw |
NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; PPL Taiwan green propolis; and NBM-BMX, an oral softgel capsule to treat cancer. The company was founded in 2000 and is based in Taipei, Taiwan.
NatureWise Biotech & Medicals Corporation Fundamentals Summary
| 4732 fundamental statistics | |
|---|---|
| Market cap | NT$1.21b |
| Earnings (TTM) | NT$15.92m |
| Revenue (TTM) | NT$180.46m |
76.2x
P/E Ratio6.7x
P/S RatioIs 4732 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4732 income statement (TTM) | |
|---|---|
| Revenue | NT$180.46m |
| Cost of Revenue | NT$81.49m |
| Gross Profit | NT$98.97m |
| Other Expenses | NT$83.05m |
| Earnings | NT$15.92m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.32 |
| Gross Margin | 54.84% |
| Net Profit Margin | 8.82% |
| Debt/Equity Ratio | 0% |
How did 4732 perform over the long term?
See historical performance and comparison